- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05525533
Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug Shopkeepers
July 13, 2023 updated by: University of California, San Francisco
The goal of the study is to operationalize and test the preliminary impact of providing regular customer feedback from adolescent girls and young women (AGYW) to drug shopkeepers on the distribution of contraceptives and HIV self-testing to AGYW over 18 months.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The investigators will cross-randomize 120 drug shops enrolled in the parent Malkia Klabu effectiveness cluster-randomized controlled trial (CRCT; NCT05357144), stratified by CRCT study arm, to one of three initial conditions: 1.
No feedback.
AGYW customer feedback will be collected, but not shared with the shopkeeper.
2. Private feedback.
Biweekly summarized reports of AGYW customer feedback will be given directly to shopkeepers.
3. Public feedback: Shopkeepers will get biweekly summarized reports of AGYW customer feedback, gold stars reflecting the level of AGYW customer feedback (e.g., 1-5 star rating) will be placed in the shop in a visible location, and shopkeepers will be invited to an awards ceremony every 6 months to recognize shopkeepers who receive high levels of positive AGYW customer feedback.
The investigators will phase in the 2 interventions (Private and Public Feedback) on a staggered basis to control for both shop-specific and time-specific trends for the primary outcomes.
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jenny X Liu, PhD
- Phone Number: 4155025200
- Email: jenny.liu2@ucsf.edu
Study Contact Backup
- Name: Calvin Chiu, MA
- Email: calvin_chiu@berkeley.edu
Study Locations
-
-
-
Mwanza, Tanzania
- Recruiting
- Mwanza Province
-
Contact:
- Jenny X Liu, PhD
- Phone Number: 4155025200
- Email: jenny.liu2@ucsf.edu
-
Shinyanga, Tanzania
- Recruiting
- Shinyanga
-
Contact:
- Jenny X Liu, PhD
- Phone Number: 4155025200
- Email: jenny.liu2@ucsf.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Shopkeepers enrolled in the parent CRCT
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: No feedback
AGYW customer feedback will be collected but not shared with shopkeepers
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
Experimental: Private feedback
Biweekly summarized reports of AGYW customer feedback will be given directly to shopkeepers
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
Experimental: Public feedback
Shopkeepers will get biweekly summarized reports of AGYW customer feedback, gold stars reflecting the level of AGYW customer feedback (e.g., 1-5 star rating) will be placed in the shop in a visible location, and shopkeepers will be invited to an awards ceremony every 6 months to recognize shopkeepers who receive high levels of positive AGYW customer feedback
|
The investigators will collect AGYW customer feedback using a short USSD-based survey and randomize whether shopkeepers receive 1) No feedback; 2) Private feedback; or 3) Public feedback
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantity of HIV self-test kits distributed
Time Frame: 12 months
|
Mean number of HIV self-test kits distributed per shop every 2 weeks
|
12 months
|
Quantity of HIV self-test kits distributed
Time Frame: 18 months
|
Mean number of HIV self-test kits distributed per shop every 2 weeks
|
18 months
|
Quantity of contraceptives distributed
Time Frame: 12 months
|
Mean number of contraceptives distributed per shop every 2 weeks
|
12 months
|
Quantity of contraceptives distributed
Time Frame: 18 months
|
Mean number of contraceptives distributed per shop every 2 weeks
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quantity of HIV self-test kits stocked
Time Frame: 12 months
|
Mean number of HIV self-test kits stocked per shop every 2 weeks
|
12 months
|
Quantity of HIV self-test kits stocked
Time Frame: 18 months
|
Mean number of HIV self-test kits available in the shop to be sold every 2 weeks
|
18 months
|
Quantity of contraceptives stocked
Time Frame: 12 months
|
Mean number of contraceptives available in the shop to be sold every 2 weeks
|
12 months
|
Quantity of contraceptives stocked
Time Frame: 18 months
|
Mean number of contraceptives available in the shop to be sold every 2 weeks
|
18 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jenny X Liu, PhD, University of California, San Francisco
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hunter LA, McCoy SI, Rao A, Mnyippembe A, Hassan K, Njau P, Mfaume R, Liu JX. Designing drug shops for young women in Tanzania: applying human-centred design to facilitate access to HIV self-testing and contraception. Health Policy Plan. 2021 Nov 11;36(10):1562-1573. doi: 10.1093/heapol/czab084.
- Chiu C, Hunter LA, McCoy SI, Mfaume R, Njau P, Liu JX. Sales and pricing decisions for HIV self-test kits among local drug shops in Tanzania: a prospective cohort study. BMC Health Serv Res. 2021 May 6;21(1):434. doi: 10.1186/s12913-021-06432-1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
August 30, 2022
First Submitted That Met QC Criteria
August 30, 2022
First Posted (Actual)
September 1, 2022
Study Record Updates
Last Update Posted (Actual)
July 14, 2023
Last Update Submitted That Met QC Criteria
July 13, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- R03HD109561-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The investigators will make the data and associated documentation available to users upon request and only under a data-sharing agreement with the study team that provides for: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate computer technology; and (3) a commitment to destroying the data after analyses are completed.
IPD Sharing Time Frame
The SP, SAP, and ICF will be made available on the Open Science Framework (OSF) within 12 months recruitment.
Study results will be posted to OSF and Clinical Trials within 12 months of completion of data collection.
IPD Sharing Access Criteria
Everything posted to OSF and Clinical Trials will be made publicly available.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hiv
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRecruitingHIV | HIV Testing | HIV Linkage to Care | HIV TreatmentUnited States
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement and other collaboratorsUnknownHIV | HIV-uninfected Children | Children Exposed to HIVCameroon
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationCompletedPartner HIV Testing | Couple HIV Counseling | Couple Communication | HIV IncidenceCameroon, Dominican Republic, Georgia, India
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CDC FoundationGilead SciencesUnknownHIV Preexposure Prophylaxis | HIV ChemoprophylaxisUnited States
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); Fenway Community Health; Tuberculosis...CompletedHIV/STI Risk | HIV/STI IncidenceUnited States, India
-
Hospital Clinic of BarcelonaCompletedIntegrase Inhibitors, HIV; HIV PROTEASE INHIBSpain
-
Erasmus Medical CenterNot yet recruitingHIV Infections | Hiv | HIV-1-infection | HIV I InfectionNetherlands
-
University of WashingtonNational Institute of Mental Health (NIMH)RecruitingHIV Prevention | HIV Preexposure Prophylaxis | ImplementationKenya
Clinical Trials on Harnessing prosocial and social image motivations for behavior change
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingObesity | Overweight | Overweight and ObesityUnited States
-
National Research Centre, EgyptEgyptian Liver HospitalCompletedHepatitis C and B VIRUS Screening, Awareness and Behavior Assessment and Evaluation for All Inhabitants Above Twelve Years of Al Othmaneya Village
-
University of California, San FranciscoCompletedPhysical InactivityUnited States
-
Massachusetts Institute of TechnologyMcGill University; United States Agency for International Development (USAID); Kehea... and other collaboratorsCompletedTuberculosis | Adherence, Medication | Drug-resistant Tuberculosis | Adherence, PatientKenya
-
Boston Medical CenterNational Institute of Mental Health (NIMH)CompletedDepressionUnited States
-
University of California, BerkeleyCompletedEveningness/SleepUnited States
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH); The Fenway InstituteUnknownMedication Adherence | Body Image DisturbanceUnited States
-
University Health Network, TorontoSunnybrook Health Sciences Centre; University of British Columbia; Nova Scotia... and other collaboratorsUnknownChronic DiseaseCanada
-
Karolinska InstitutetCompletedStroke | Transient Ischemic AttackSweden
-
Aga Khan UniversityUnited Nations World Food Programme (WFP); Aga Khan Health Services; Ministry... and other collaboratorsCompletedStunting | Malnutrition, ChildAfghanistan